The features that differentiate ALCL from other types of CD30+ malignancies include co-expression of CD30 with epithelial membrane antigen and/or T cell antigens in the presence of anaplastic morphologic features (1, 2). This evidence concerns the gene TNFRSF8 and anaplastic large cell lymphoma.